Investing.com - Zai Lab reported on Tuesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Zai Lab announced earnings per share of $-0.09 on revenue of $46.72M. Analysts polled by Investing.com anticipated EPS of $-1.22 on revenue of $45.58M.
Zai Lab shares are down 58.25% from the beginning of the year and are trading at $26.24 , down-from-52-week-high.They are under-performing the Nasdaq which is down 24.97% from the start of the year.
Zai Lab follows other major Healthcare sector earnings this month
Zai Lab's report follows an earnings beat by J&J on Tuesday, April 19, 2022, who reported EPS of $2.67 on revenue of $23.43B, compared to forecasts EPS of $2.59 on revenue of $23.62B.
UnitedHealth had beat expectations on Thursday, April 14, 2022 with first quarter EPS of $5.49 on revenue of $80.15B, compared to forecast for EPS of $5.36 on revenue of $78.73B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar